Skip to main content
Robert Stapp, DO, Pathology, Tampa, FL

RobertTStappDO

Pathology Tampa, FL

Anatomic Pathology, Clinical Pathology, Clinical Informatics

Associate Chief Medical Information Officer (CMIO) for Pathology Informatics

Dr. Stapp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stapp's full profile

Already have an account?

  • Office

    12902 Usf Magnolia Dr
    Tampa, FL 33612
    Phone+1 813-745-4673

Summary

  • Dr. Robert Stapp is a pathologist in Tampa, FL and is affiliated with Moffitt Cancer Center. He received his medical degree from Kansas City University College of Osteopathic Medicine and has been in practice 10 years. He specializes in anatomic pathology and clinical pathology and is experienced in health technology/informatics, pathology, and information systems.

Education & Training

  • Henry Ford Hospital
    Henry Ford HospitalFellowship, Clinical Informatics (Pathology), 2012 - 2014
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
    Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2007

Certifications & Licensure

  • FL State Medical License
    FL State License 2021 - 2026
  • PA State Medical License
    PA State License 2014 - 2022
  • MI State Medical License
    MI State License 2007 - 2015
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Clinical Informatics

Publications & Presentations

PubMed

Journal Articles

  • Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.  
    Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM, Cell Cycle